Back to mobile site

UPDATE: JPMorgan Downgrades Atara Biotherapeutics (ATRA) to Neutral

November 8, 2019 4:21 AM EST Send to a Friend
(Updated - November 8, 2019 4:51 AM EST)

(updated comment)JPMorgan analyst Anupam Rama downgraded Atara Biotherapeutics (NASDAQ: ATRA) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login